DEVELOPMENT OF NANOPHARMACEUTICAL THERAPY FOR COMBAT-RELATED PROLIFERATIVE VITREORETINOPATHY. NEW AWARD.

$2,449,953FY2019Defense Health AgencyDOD

Metis Foundation, San Antonio TX

Investigators